1 - 25 of 61 results for author:"Frati L." in Literature citations
Results Customize
› Repeat search in UniProtKB (7)
| Syk-dependent regulation of Hrs phosphorylation and ubiquitination upon FcepsilonRI engagement: impact on Hrs membrane/cytosol localization. Gasparrini F., Molfetta R., Quatrini L., Frati L., Santoni A., Paolini R. Eur. J. Immunol. 42:2744-2753(2012) · Mapped (4) |
| Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation. Napoletano C., Zizzari I.G., Rughetti A., Rahimi H., Irimura T., Clausen H., Wandall H.H., Belleudi F., Bellati F., Pierelli L. et al. Eur. J. Immunol. 42:936-945(2012) · Mapped (2) |
| PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway. Capuano C., Paolini R., Molfetta R., Frati L., Santoni A., Galandrini R. Blood 119:2252-2262(2012) · Mapped (2) |
| Acetylation controls Notch3 stability and function in T-cell leukemia. Palermo R., Checquolo S., Giovenco A., Grazioli P., Kumar V., Campese A.F., Giorgi A., Napolitano M., Canettieri G., Ferrara G. et al. Oncogene 31:3807-3817(2012) · Mapped (3) |
| Notch3 and canonical NF-kappaB signaling pathways cooperatively regulate Foxp3 transcription. Barbarulo A., Grazioli P., Campese A.F., Bellavia D., Di Mario G., Pelullo M., Ciuffetta A., Colantoni S., Vacca A., Frati L. et al. J. Immunol. 186:6199-6206(2011) · Mapped (9) |
| Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas. Messina S., Frati L., Leonetti C., Zuchegna C., Di Zazzo E., Calogero A., Porcellini A. Oncogene 30:3813-3820(2011) · Mapped (4) |
| Dendritic cell differentiation blocked by primary effusion lymphoma-released factors is partially restored by inhibition of P38 MAPK. Cirone M., Di Renzo L., Trivedi P., Lucania G., Borgia G., Frati L., Faggioni A. Int J Immunopathol Pharmacol 23:1079-1086(2010) · Mapped (5) |
| MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response. Petroni M., Veschi V., Prodosmo A., Rinaldo C., Massimi I., Carbonari M., Dominici C., McDowell H.P., Rinaldi C., Screpanti I. et al. Mol. Cancer Res. 9:67-77(2011) · Mapped (35) |
| High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma. Ulisse S., Baldini E., Sorrenti S., Barollo S., Gnessi L., Catania A., Pellizzo M.R., Nardi F., Mian C., De Antoni E. et al. J. Clin. Endocrinol. Metab. 96:504-508(2011) · Mapped (10) |
| CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1. Sciume G., Soriani A., Piccoli M., Frati L., Santoni A., Bernardini G. Neuro-oncology 12:701-710(2010) · Mapped (10) |
| Early defect of transforming growth factor beta1 formation in Huntington's disease. Battaglia G., Cannella M., Riozzi B., Orobello S., Maat-Schieman M.L., Aronica E., Busceti C.L., Ciarmiello A., Alberti S., Amico E. et al. J. Cell. Mol. Med. 15:555-571(2011) · Mapped (9) |
| Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia. Checquolo S., Palermo R., Cialfi S., Ferrara G., Oliviero C., Talora C., Bellavia D., Giovenco A., Grazioli P., Frati L. et al. Oncogene 29:1463-1474(2010) · Mapped (4) |
| Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy. Napoletano C., Rughetti A., Landi R., Pinto D., Bellati F., Rahimi H., Spinelli G.P., Pauselli S., Sale P., Dolo V. et al. Int J Immunopathol Pharmacol 22:647-658(2009) · Mapped (8) |
| Notch3 and pTalpha/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells. Campese A.F., Grazioli P., Colantoni S., Anastasi E., Mecarozzi M., Checquolo S., De Luca G., Bellavia D., Frati L., Gulino A. et al. Int. Immunol. 21:727-743(2009) · Mapped (1) |
| Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells. Salvatori L., Caporuscio F., Coroniti G., Starace G., Frati L., Russo M.A., Petrangeli E. J. Cell. Physiol. 220:35-44(2009) · Mapped (19) |
| Tenascin C: a defensive role in sentinel lymph nodes of melanoma patients? Gazzaniga P., Cigna E., Vincenzi B., Bottoni U., Vasaturo F., Alfano C., Calvieri S., Frati L., Scuderi N., Agliano A.M. et al. J. Dermatol. Sci. 53:239-241(2009) · Mapped (6) |
| Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy. Gradilone A., Pulcinelli F.M., Lotti L.V., Trifiro E., Martino S., Gandini O., Gianni W., Frati L., Agliano A.M., Gazzaniga P. Curr Cancer Drug Targets 8:414-420(2008) · Mapped (15) |
| PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. Micucci F., Capuano C., Marchetti E., Piccoli M., Frati L., Santoni A., Galandrini R. Blood 111:4165-4172(2008) · Mapped (9) |
| Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications. Gradilone A., Pulcinelli F.M., Lotti L.V., Martino S., Mattiello T., Frati L., Agliano A.M., Gazzaniga P. J. Clin. Oncol. 25:4318-20; author reply 2007:4320-4320(2007) · Mapped (8) |
| The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway. Peruzzi G., Molfetta R., Gasparrini F., Vian L., Morrone S., Piccoli M., Frati L., Santoni A., Paolini R. J. Immunol. 179:2089-2096(2007) · Mapped (4) |
| AKT and MAPK signaling in KGF-treated and UVB-exposed human epidermal cells. Lotti L.V., Rotolo S., Francescangeli F., Frati L., Torrisi M.R., Marchese C. J. Cell. Physiol. 212:633-642(2007) · Mapped (10) |
| Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Cerboni C., Zingoni A., Cippitelli M., Piccoli M., Frati L., Santoni A. Blood 110:606-615(2007) · Mapped (2) |
| Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families. Buffone A., Capalbo C., Ricevuto E., Sidoni T., Ottini L., Falchetti M., Cortesi E., Marchetti P., Scambia G., Tomao S. et al. Breast Cancer Res. Treat. 106:289-296(2007) · Mapped (18) |
| Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing. Bellavia D., Mecarozzi M., Campese A.F., Grazioli P., Talora C., Frati L., Gulino A., Screpanti I. EMBO J. 26:1670-1680(2007) · Mapped (8) |
| EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells. Boccellato F., Anastasiadou E., Rosato P., Kempkes B., Frati L., Faggioni A., Trivedi P. J. Virol. 81:2274-2282(2007) · Mapped (1) |